The injected medication binds to GLP-1 receptors throughout your body, particularly in the pancreas, stomach, and brain regions controlling appetite
Per injection: at 10 units (loading) GHK-Cu 2.50 mg, KPV 500 mcg, BPC-157 500 mcg, TB-500 500 mcg
GLP-1 receptor agonists are expensive medications, and without robust efficacy data for addiction treatment, their use for this indication cannot be justified from a health economics perspective
You might experience slight arm soreness, temporary metallic taste, or mild dizziness when standing
Yes, if prescribed by a licensed healthcare provider for a medically recognized condition such as obesity (BMI 30), type 2 diabetes, or metabolic syndrome